Connect with us

Technology

Chiesi launches innovation platform focused on partnership and patient care: The Impulse

Published

on

PARMA, Italy, Oct. 18, 2024 /PRNewswire/ — Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and meaningful partnerships in healthcare. The Impulse aims to tackle some of the biggest challenges facing patients, planet, and people today by addressing not only healthcare symptoms but also the root causes of these challenges, such as climate change and access to care.

Empowering innovation through collaboration

The Impulse is stepping in to fill the growing demand for innovative solutions that meet the real needs of patients. By creating a collaborative space for researchers, start-ups, and innovators to work together, The Impulse is driving forward-thinking healthcare solutions—from digital health advancements to sustainable patient care models—that have the potential to transform how we think about and deliver healthcare.

“We stand at a pivotal moment for the pharmaceutical industry. This is the time to further rethink traditional models and embrace bolder, patient-centric innovation. That’s why Chiesi has created The Impulse, aiming to empower those who are driven by a passion to improve the lives of others through innovation,” said Fabrizio Conicella, Vice-President Center of Open Innovation & Competence. “We know that some of the most groundbreaking ideas come from collaboration. By providing the resources, network, and support, we aim to accelerate ideas that will have a tangible impact on patients and the world around us, perfectly in line with our Company vision.”

A commitment to patients and the planet

The launch of The Impulse is particularly timely, as the healthcare industry faces increasing pressure to rethink traditional care models. With climate change and environmental sustainability now central to global health discussions, The Impulse is committed to fostering solutions that not only improve patient outcomes but also contribute to a healthier planet.

The Impulse has already begun to attract interest from key players in the life sciences, digital health, and environmental sustainability sectors, including the Karolinska Institutet, NOME and EIT-HEALTH, with many more partnerships in the pipeline.

For more information on The Impulse and how to get involved, visit https://www.chiesi.com/en/about-us/the-impulse/.

View original content:https://www.prnewswire.co.uk/news-releases/chiesi-launches-innovation-platform-focused-on-partnership-and-patient-care-the-impulse-302279557.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Taiwan’s Machinery Enterprises Are Powering Industrial Automation

Published

on

By

Their deep, diverse expertise and cutting-edge technological capabilities are helping manufacturers worldwide overcome automation challenges

TAIPEI, Oct. 18, 2024 /PRNewswire/ — Taiwan External Trade Development Council (TAITRA) is unveiling several case studies that demonstrate how Taiwanese machinery and metalworking enterprises are driving industrial automation.

To explore collaborations with leading companies in automation and machinery, TAITRA can connect you with top Taiwanese suppliers in the field: https://innovation.taitra.org.tw/en/supplier-list

Or email: IndustryMarketingTeam@taitra.org.tw

Solving challenges for implementing automation

A recent McKinsey report identified automation as the top investment priority across sectors from 2023 to 2029. However, there remain several challenges to scaling up automation, including:

Selecting the appropriate technologyPlanning implementationAcquiring specialized automation expertise

With diverse expertise and deep experience, Taiwan’s machinery companies are uniquely positioned to solve these challenges and advance automation worldwide.

A legacy of empowering manufacturing across industries

Taiwan has enormous diversity and depth of experience in machinery, metalworking, and manufacturing. A majority of its companies are leading experts in their specific fields worldwide and offer decades of experience — in some cases over half a century.

This deep expertise spans a diverse range of industries, including:

Powder production: Mill Powder Tech Co., Ltd. brings nearly 80 years of experience in technologies for powder manufacturing, serving both food and pharmaceutical industries with precision solutions.Screw manufacturing: Chien Tsai Machinery Enterprise Co., Ltd. has robust capabilities in screw manufacturing, delivering high-output, precision-engineered equipment that meet exacting global standards.Welding machinery: Dahching Electric Industrial Co., Ltd. leads in welding machinery innovation, contributing significantly to the production of high-quality welded components across industries.

As ODM and OEM partners, Taiwanese companies embrace the role of consultant for clients, advising them on how to optimize designs and focusing on long-term success. Two examples are Mill Powder Tech and CTT, which leverage extensive customization capabilities while guiding clients in achieving their goals.

Enabling Industry 5.0 and upscaling productivity

Automation and high-performance facilities require technologies like computer-numerical control (CNC) and turnkey solutions from experts that can serve as a one-stop shop. Numerous Taiwanese companies are innovating in these areas, including:

Advanced CNC integration: CTT serves as a one-stop shop for integrating processes and solutions, including CNC-based automation for handling complex manufacturing needs.Comprehensive turnkey solutions: Mill Powder Tech offers a complete turnkey system that enhances both quality and productivity, eliminating the complexity of managing multiple vendors and ensuring smooth implementation.

A key partner worldwide 

Taiwan’s business community has several advantages to offer:  

Technological capabilities: Robust R&D and patented, proprietary technologiesTrustworthy and reliable: Highly sensitive to and diligent about protecting partner intellectual propertyCustomer-centric: Flexibility and customization for specific needsESG: Embrace sustainability in operations and supply chainsCompatible with friendshoring efforts: With operations and networks worldwide for business continuity

Helping international buyers access the best of Taiwan

When searching for a supplier or partner overseas, companies often struggle with finding a suitable company that is trustworthy and reliable, and then communication can pose additional challenges. To accelerate this process and foster impactful synergies, TAITRA serves as a resource and facilitates collaborating with the island’s most unique, forward-looking startups and enterprises.  

The organization solves the pain points of international buyers with the following services:

Consultations on needs and matching services: https://innovation.taitra.org.tw/en/contact-usExtensive list of companies available online for free: https://innovation.taitra.org.tw/en/supplier-listPre-vetting and screening companies as reliable and trustworthyFacilitating communication and ensuring successful contact is made

To ensure buyers collaborate with high-integrity businesses, TAITRA has established real-time, borderless services through a comprehensive trade network of over 60 overseas offices in more than 40 countries worldwide, and the organization holds cooperation agreements with over 500 international trade-related sister organizations.

Photo – https://mma.prnewswire.com/media/2534413/Mill_Powder_Tech_Solutions_for_high_speed_crash_milling_with_precision_and_efficiency___1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/taiwans-machinery-enterprises-are-powering-industrial-automation-302280255.html

Continue Reading

Technology

111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow

Published

on

By

SHANGHAI, Oct. 18, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024.

111’s management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 28, 2024 (8:30 PM Beijing Time on the same day).

Details for the conference call are as follows:

Conference Topic: 111, Inc. Third Quarter 2024 Earnings Conference Call
Registration Link: https://s1.c-conf.com/diamondpass/10042738-te7sgd.html

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will then be provided with the dial in number, the Passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

Please dial in 15 minutes before the call is scheduled to begin. To join the conference, simply dial the number in the calendar invite and enter the passcode followed by your PIN, and you will join the conference instantly.

A live and archived webcast of the conference call will be available on the website at https://edge.media-server.com/mmc/p/3nkscjv6

A telephone replay of the call will be available after the conclusion of the conference call until December 5, 2024.

China: 4001209216
United States: +1-855-883-1031
International: +61-7-3107-6325
Conference ID: 10042738

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company’s online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

View original content:https://www.prnewswire.com/news-releases/111-to-announce-third-quarter-2024-unaudited-financial-results-on-november-28-2024—conference-call-to-follow-302280169.html

SOURCE 111, Inc.

Continue Reading

Technology

Eruditus Secures $150 Million Series F Funding Led by TPG’s The Rise Fund

Published

on

By

With participation from existing investors Softbank Vision Fund 2, Leeds Illuminate, Accel, CPP Investments and the Chan Zuckerberg Initiative

Eruditus, the parent company of Emeritus, closes funding round to deepen investment in AI products and accelerate growth of enterprise business after achieving profitability

MUMBAI, India, Oct. 18, 2024 /PRNewswire/ — Eruditus, the global leader in making high-quality education accessible and affordable to individuals, companies, and governments around the world, announced today that it has raised a $150 million Series F fundraise led by TPG’s The Rise Fund, the multi-sector strategy of TPG’s global impact investing platform, with participation from existing investors Softbank Vision Fund 2, Leeds Illuminate, Accel, CPP Investments and the Chan Zuckerberg Initiative. This highlights the company’s remarkable growth and impact through continuous innovation in high-quality career-oriented education across the globe. The raise comes on the heels of a banner year for Eruditus in which the company was named the #1 Global EdTech by Time and achieved profitability on a full-year basis.

The funding bolsters Eruditus’ global growth and will be used to invest in AI technology to further enrich the learner experience, expand the company’s rapidly growing business serving governments and enterprises and deepen its investments in the India and APAC regions. As the company continues to grow and scale, it eyes future acquisitions and investments, which have historically contributed to impressive topline growth and expansion in strategic markets. Avendus Capital was the exclusive financial advisor for the fundraise.

Eruditus’ mission to make high quality education accessible and affordable around the world has never been more critical. Business today is changing faster than ever—and the AI revolution means it’s set to change even faster. The company is accelerating its investments in technology to harness the power of generative AI to further enrich the learner experience and provide enhanced learning solutions. Eruditus has already launched proprietary AI-powered tutors for students and programs with partner schools. The need for training in the age of AI is driving unprecedented demand for the company’s enterprise solutions that grew revenue 45% last year.

Steve Ellis, a Managing Partner of The Rise Funds, said “Eruditus is expanding access to new education opportunities and giving professionals at all stages of their careers the skills they need to advance and succeed in today’s rapidly changing workplace. Eruditus’ mission aligns with a core investing theme for The Rise Funds, which focuses on backing strong businesses that are opening pathways to high quality education and driving greater lifetime earning potential for their students. We look forward to working with Eruditus to further enhance the platform and scale the business globally.” As part of The Rise Fund’s investment, TPG’s Simit Batra will join Eruditus’ board of directors.

Today, more than 80+ top tier university partners around the world work with Eruditus to create over 700 professional learning programs delivered to more than 1 million individuals in 80+ countries. The company’s industry-driven certification programs, professional certificates, and workforce leadership development initiatives are defined by personal engagement between faculty and students, course customization, mentoring and coaching, and career counseling. The results are evident in course completion rates of 85% for their professional learners.

“With this investment, we’re excited to continue to grow and innovate to meet market demand,” said Ashwin Damera, CEO, Eruditus and Emeritus. “In a rapidly evolving business environment, we have reimagined education by bringing programs from the world’s leading universities to learners around the globe. Education is the key to transformation, for individuals, companies, and society and we’re appreciative of the support of our investors who enable us to accelerate our growth.”

About Eruditus
Eruditus, the parent company of Emeritus, is committed to teaching the skills of the future by making high-quality education accessible and affordable to individuals, organizations, and governments worldwide. It does this by collaborating with more than 80 top-tier universities across the United States, Europe, Latin America, Southeast Asia, India, and China. Eruditus’ short courses, degree programs, professional certificates, and senior executive programs help individuals learn new skills and transform their lives, companies, and organizations. Its unique model of state-of-the-art technology; curriculum innovation; and hands-on instruction from senior faculty, mentors, and coaches has educated more than 1 million individuals across 80+ countries. The Eruditus Group has more than 1,750 employees globally and offices in Mumbai, New Delhi, Shanghai, Singapore, Palo Alto, Mexico City, New York, Boston, London, and Dubai. The company is backed by TPG, the Chan Zuckerberg Initiative, Leeds Illuminate, Prosus Ventures, GSV Ventures, Peak XV, Bertelsmann, CPP Investments, Accel and SoftBank Vision Fund 2. For more information, please visit www.Emeritus.org.

About The Rise Funds
The Rise Funds are a core pillar of TPG Rise, TPG’s global impact investing platform. Founded in 2016, The Rise Funds invest behind impact entrepreneurs and growth-stage, high potential, mission-driven companies that are focused on achieving the United Nations’ Sustainable Development Goals. The Rise Funds deliver capabilities and expertise across a wide variety of sectors and countries at scale, focusing on opportunities in climate and conservation, education, food and agriculture, financial inclusion, healthcare, and impact services.

With approximately $19 billion in assets across The Rise Funds, TPG Rise Climate, and the Evercare Health Fund, the TPG Rise platform is one of the world’s largest private markets impact investing platforms committed to achieving measurable, positive social and environmental outcomes alongside competitive financial returns.

For more information, visit therisefund.com.

Logo – https://mma.prnewswire.com/media/2534293/Emeritus_Rise.jpg

View original content:https://www.prnewswire.co.uk/news-releases/eruditus-secures-150-million-series-f-funding-led-by-tpgs-the-rise-fund-302280128.html

Continue Reading

Trending